Font Size: a A A
Keyword [epidermal growth factor receptor(EGFR)]
Result: 121 - 140 | Page: 7 of 9
121. The Relationship Between Epidermal Growth Factor Receptor (EGFR) Mutation And Histologic Subtype According To New Classification (IASLC/ATS/ERS In 2011) And Clinical Characteristics In Stageā… lung Adenocarcinoma
122. The Correlation For Expression Of EGFR And 4EBP1 In Different Biological Subtype Breast Carcinoma
123. Preliminary Study On The Mechanism Of Gefitinib Inhibiting EGFR Signaling Pathway Affecting Long Bone Fracture Healing In Rats
124. CT Radiomic Features Predicting Epidermal Growth Factor Receptor Mutation In Peripheral Lung Adenocarcinoma
125. Comparative Study Of EGFR Mutations Detected By Peripheral Blood CtDNA And CTCs Based On Patients With Advanced NSCLC
126. Model To Predict PFS Of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors In Chinese Han Lung Adenocarcinoma Population
127. Dual-Phase 18F-FDG PET/CT For Predicting EGFR Mutations In Patients With Non-Small Cell Lung Cancer
128. Process Research Of Osimertinib And Design,Synthesis And Preliminary Activity Study Of EGFR And HDACs Dual-Target Inhibitors
129. MICAL2 Promotes Breast Cancer Cell Migration By Maintaining Epidermal Growth Factor Receptor (EGFR) Stability And EGFR/P38 Signalling Activation
130. Bypass Activation Of EGFR Signaling In EGFR Mutant Lung Adenocarcinoma Cells And Its Cross-linking Regulation With B7-H3 Signaling
131. The Effets Of KIAA1199 On Tumorgenesis And Development Of Non-small Cell Cancer And Relative Mechanism
132. EGFR Mutations In Patients With Advanced NSCLC Complicated With COPD And The Response And Prognosis Of EGFR-TKIs Treatment
133. Correlation Between DCE-MRI And DWI Imaging Features Of Breast Cancer And EGFR And P120ctn Expression
134. Research On The Correlation Between EGF, EGFR, PSA And Prostate Hyperplasia And Prostate Cancer
135. The Effect Of Moxibustion At Guanyuan And Zusanli On The Expression Of MUC2 And EGFR In Rats With Ulcerative Colitis
136. Regulation of epidermal growth factor receptor endocytosis
137. A novel small molecule-based multi-targeting approach for the selective therapy of epidermal growth factor receptor (EGFR)- or Her2-expressing carcinomas
138. Receptor-Mediated Uptake and Intracellular Sorting of Multivalent Lipid Nanoparticles Against the Epidermal Growth Factor Receptor (EGFR) and the Human EGFR 2 (HER2)
139. An antagonist of the prostaglandin F2alpha receptor (FP)-Galphaq-dependent response, biases FP into mitogen-activated protein kinase (MAPK) signalling through epidermal growth factor receptor (EGFR) transactivation
140. Epidermal growth factor receptor (EGFR) mutations and tumor-specific targeting of malignant glioma by vaccine-based immunotherapeutic approaches
  <<First  <Prev  Next>  Last>>  Jump to